AAAAAA

   
Results: 1-20 |
Results: 20

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO C BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903

Authors: BACIGALUPO A VANLINT BM LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S ZIKOS P LOMBARDI A
Citation: A. Bacigalupo et al., EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN, Experimental hematology, 26(8), 1998, pp. 368-368

Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414

Authors: MORETTI S ZIKOS P VANLINT MT TEDONE E OCCHINI D GUALANDI F LAMPARELLI T MORDINI N BERISSO G BREGANTE S BRUNO B BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180

Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38

Authors: ZIKOS PM VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M VITALE V BARRA S CORVO R BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39

Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40

Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121

Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357

Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490

Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S DESTEFANO F SORACCO M VITALE V BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508

Authors: BACIGALUPO A SORACCO M VASSALLO F ABATE M VANLINT MT GUALANDI F LAMPARELLI T OCCHINI D MORDINI N BREGANTE S FIGARI O BENVENUTO F SESSAREGO M FUGAZZA G CARLIER P VALBONESI M
Citation: A. Bacigalupo et al., DONOR LYMPHOCYTE INFUSIONS (DLI) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(9), 1997, pp. 927-932

Authors: PODESTA M PIAGGIO G FRASSONI F PITTO A MORDINI N BREGANTE S VALERIANI A BACIGALUPO A
Citation: M. Podesta et al., DEFICIENT RECONSTITUTION OF EARLY PROGENITORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(10), 1997, pp. 1011-1017

Authors: BACIGALUPO A MORDINI N PITTO A PIAGGIO G PODESTA M BENVENUTO F VANLINT MT VALBONESI M LERCARI G CARLIER P LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S FIGARI O SORACCO M VASSALLO F DESTEFANO G
Citation: A. Bacigalupo et al., TRANSPLANTATION OF HLA-MISMATCHED CD34(- SEVERE IMMUNODEFICIENCY AND RELATED COMPLICATIONS() SELECTED CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES ), British Journal of Haematology, 98(3), 1997, pp. 760-766

Authors: MIKHAILOVA N SESSAREGO M FUGAZZA G CAIMO A DEFILIPPI S VANLINT MT BREGANTE S VALERIANI A MORDINI N LAMPARELLI T GUALANDI F OCCHINI D BACIGALUPO A
Citation: N. Mikhailova et al., CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Haematologica, 81(5), 1996, pp. 418-422

Authors: BACIGALUPO A BREGANTE S TEDONE E ISAZA A VANLINT MT MORO F TRESPI G OCCHINI D GUALANDI F LAMPARELLI T MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT), Bone marrow transplantation, 18, 1996, pp. 110-114

Authors: BACIGALUPO A BREGANTE S TEDONE E ISAZA A VANLINT MT TRESPI G OCCHINI D GUALANDI F LAMPARELLI T MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Transplantation, 62(3), 1996, pp. 376-380

Authors: BACIGALUPO A VANLINT MT VALBONESI M LERCARI G CARLIER P LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S VALERIANI A PIAGGIO G PITTO A BENVENUTO F FIGARI O DESTEFANO G CAIMO A SESSAREGO M
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD CELLS IN ADULTS WITH ADVANCED LEUKEMIA, Blood, 88(1), 1996, pp. 353-357

Authors: BACIGALUPO A VANLINT MT VALBONESI F LERCARI G CARLIER P LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S VALERIANI A PIAGGIO G PITTO A BENVENUTO F FIGARI O DESTEFANO G CAIMO A SESSAREGO M
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL-BLOOD CELLS FROM HLAIDENTICAL SIBLINGS IN ELDERLY PATIENTS WITH ADVANCED LEUKEMIA, Blood, 86(10), 1995, pp. 377-377
Risultati: 1-20 |